Cargando…

Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire

BACKGROUND: Although COVID-19 has spread in Côte d’Ivoire, there is no report that summarizes the comorbidities of COVID-19 death cases. OBJECTIVE: To verify the types and prevalence of commodities associated with recorded COVID-19 deaths compared with the general adult population in Côte d’Ivoire....

Descripción completa

Detalles Bibliográficos
Autores principales: Usui, Rui, Kanamori, Shogo, Aomori, Maki, Watabe, Setsuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667576/
https://www.ncbi.nlm.nih.gov/pubmed/36405523
http://dx.doi.org/10.4081/jphia.2022.1748
_version_ 1784831751306084352
author Usui, Rui
Kanamori, Shogo
Aomori, Maki
Watabe, Setsuko
author_facet Usui, Rui
Kanamori, Shogo
Aomori, Maki
Watabe, Setsuko
author_sort Usui, Rui
collection PubMed
description BACKGROUND: Although COVID-19 has spread in Côte d’Ivoire, there is no report that summarizes the comorbidities of COVID-19 death cases. OBJECTIVE: To verify the types and prevalence of commodities associated with recorded COVID-19 deaths compared with the general adult population in Côte d’Ivoire. METHODS: Data on the comorbidities of COVID-19 deaths and the country’s disease structure were collected from official government reports and WHO’s reports. RESULTS: Among 67 patients studied, the biggest age group was 60-69 years old with 23 people (34%). Fifty-four patients (81%) had non-communicable diseases (NCDs) as comorbidities. The prevalence ratio between COVID-19 deaths and general adult population was 8.96 [95% Confidence Interval: 6.86-11.68] for diabetes, 1.74 [1.27-2.37] for hypertension, and 2.16 [1.32-3.51] for obesity. CONCLUSIONS: To reduce the risk of death from COVID-19 in Côte d’Ivoire, focused infection prevention measures for elderly and diabetic patients are needed.
format Online
Article
Text
id pubmed-9667576
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-96675762022-11-17 Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire Usui, Rui Kanamori, Shogo Aomori, Maki Watabe, Setsuko J Public Health Afr Brief Reports BACKGROUND: Although COVID-19 has spread in Côte d’Ivoire, there is no report that summarizes the comorbidities of COVID-19 death cases. OBJECTIVE: To verify the types and prevalence of commodities associated with recorded COVID-19 deaths compared with the general adult population in Côte d’Ivoire. METHODS: Data on the comorbidities of COVID-19 deaths and the country’s disease structure were collected from official government reports and WHO’s reports. RESULTS: Among 67 patients studied, the biggest age group was 60-69 years old with 23 people (34%). Fifty-four patients (81%) had non-communicable diseases (NCDs) as comorbidities. The prevalence ratio between COVID-19 deaths and general adult population was 8.96 [95% Confidence Interval: 6.86-11.68] for diabetes, 1.74 [1.27-2.37] for hypertension, and 2.16 [1.32-3.51] for obesity. CONCLUSIONS: To reduce the risk of death from COVID-19 in Côte d’Ivoire, focused infection prevention measures for elderly and diabetic patients are needed. PAGEPress Publications, Pavia, Italy 2022-10-25 /pmc/articles/PMC9667576/ /pubmed/36405523 http://dx.doi.org/10.4081/jphia.2022.1748 Text en ©Copyright: the Author(s) https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Brief Reports
Usui, Rui
Kanamori, Shogo
Aomori, Maki
Watabe, Setsuko
Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire
title Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire
title_full Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire
title_fullStr Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire
title_full_unstemmed Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire
title_short Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire
title_sort analysis of covid-19 mortality in patients with comorbidities in côte d’ivoire
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667576/
https://www.ncbi.nlm.nih.gov/pubmed/36405523
http://dx.doi.org/10.4081/jphia.2022.1748
work_keys_str_mv AT usuirui analysisofcovid19mortalityinpatientswithcomorbiditiesincotedivoire
AT kanamorishogo analysisofcovid19mortalityinpatientswithcomorbiditiesincotedivoire
AT aomorimaki analysisofcovid19mortalityinpatientswithcomorbiditiesincotedivoire
AT watabesetsuko analysisofcovid19mortalityinpatientswithcomorbiditiesincotedivoire